Quantitative analysis for Tekla Life Sciences Investors (HQL) — Financials: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (61.0) (grade B). 27 signals analyzed (23 differentiated alt-data).
HQL stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $17.63 | $17.29 | $17.40 |
| 2026-05-11 | $18.46 | $18.10 | $18.11 |
| 2026-05-21 | $17.24 | $17.00 | $17.21 |
| 2026-06-03 | $17.13 | $16.90 | $16.93 |
| 2026-06-15 | $17.25 | $17.01 | $17.16 |
| 2026-06-26 | $19.40 | $19.01 | $19.25 |
| 2026-07-09 | $21.08 | $20.62 | $20.83 |
| 2026-07-21 | $19.86 | $19.40 | $19.83 |
| 2026-07-31 | $19.55 | $19.00 | $19.10 |
| 2026-08-12 | $21.30 | $21.00 | $21.24 |
| 2026-08-24 | $21.59 | $21.26 | $21.55 |
| 2026-09-03 | $21.17 | $20.42 | $20.71 |
How Tekla Life Sciences Investors stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ECC | Eagle Point Credit Company Inc. | $538M | — |
| DSU | BlackRock Debt Strategies Fund, Inc. | $536M | — |
| CHW | Calamos Global Dynamic Income Fund | $540M | — |
| MSIF | MSC Income Fund, Inc. | $541M | — |
View all Financials stocks by valuation and signals →
Tekla Life Sciences Investors (HQL) scores Buy (61.0), with no measured dimension below 58. Its highest are valuation at 72, across 2 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| valuation | 72 |
| technicals | 58 |
StoQuant analyzes 27 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Financials Hub — Top performers and valuation outliers in Financials
Get daily updates on Tekla Life Sciences Investors (HQL): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/HQL"><img src="https://stoquant.com/badge/HQL.svg" alt="Tekla Life Sciences Investors (HQL) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.